EVO
Evotec SE Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website evotec.com
- Employees(FY) 5086
- ISIN US30050E1055
Performance
-1.06%
1W
+13.08%
1M
+39.82%
3M
-2.3%
6M
-60.19%
YTD
-52.78%
1Y
Profile
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals, as well as a strategic partnership with Dewpoint Therapeutics to advance oncology pipeline programs of condensate modifying therapeutics to investigational new drug applications and a licensing agreement with Glycotope GmbH to develop next generation immune cell engaging bispecifics for various potential indications, including solid tumors The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Technical Analysis of EVO 2024-12-10
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-29 02:00
Evotec Announces Change in Management Board(ACCESSWIRE)
- 2024-11-28 13:00
Evotec Announces Change in Management Board(Accesswire)
- 2024-11-24 17:49
Analyst Report: Evotec SE(Morningstar Research)
- 2024-11-22 11:15
Comment on Withdrawn Non-Binding Offer(ACCESSWIRE)
- 2024-11-22 08:35
- 2024-11-21 22:15
Comment on Withdrawn Non-Binding Offer(Accesswire)
- 2024-11-21 19:35
- 2024-11-20 00:14
Analyst Report: Evotec SE(Morningstar Research)
- 2024-11-19 05:01
Is Evotec SE (EVO) the Best German Stock to Buy Now?(Insidermonkey)
- 2024-11-18 19:47
Analyst Report: Evotec SE(Morningstar Research)
- 2024-11-18 07:00
- 2024-11-17 18:00
- 2024-11-15 22:45
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover(Morningstar Research)
- 2024-11-15 15:43
Analyst Report: Evotec SE(Morningstar Research)
- 2024-11-14 17:30
Comment on Media Report(ACCESSWIRE)
- 2024-11-14 16:15
- 2024-11-14 04:30
Comment on Media Report(Accesswire)
- 2024-11-14 03:15
- 2024-11-12 01:13
Evotec Third Quarter 2024 Earnings: Misses Expectations(Simply Wall St.)
- 2024-11-10 01:09
- 2024-11-07 08:37
Analyst Report: Evotec SE(Morningstar Research)
- 2024-11-06 01:20
- 2024-11-05 12:20
- 2024-11-05 01:50
- 2024-11-04 19:18
Analyst Report: Evotec SE(Morningstar Research)
- 2024-11-04 12:50
- 2024-10-30 03:30
- 2024-10-29 15:30
- 2024-10-23 02:00
- 2024-10-22 14:00
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.